Lemaitre Vascular (LMAT) Change in Accured Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Change in Accured Expenses for 17 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 200.0% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$359000.0 (down 112.18% YoY), while the FY2025 annual figure was $1.8 million, up 294.69% from the prior year.
• Change in Accured Expenses eased to -$1.1 million in Q1 2026 per LMAT's latest filing, from $1.1 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $4.3 million in Q3 2024 and bottomed at -$3.4 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged $25941.2 across 5 years, with a median of $35000.0 in 2022.
• On a YoY basis, Change in Accured Expenses climbed as much as 9157.14% in 2023 and fell as far as 580.38% in 2023.
• Lemaitre Vascular's Change in Accured Expenses stood at $469000.0 in 2022, then slumped by 580.38% to -$2.3 million in 2023, then jumped by 59.03% to -$923000.0 in 2024, then jumped by 216.79% to $1.1 million in 2025, then slumped by 200.0% to -$1.1 million in 2026.
• Business Quant data shows LMAT's Change in Accured Expenses at -$1.1 million in Q1 2026, $1.1 million in Q4 2025, and $2.0 million in Q3 2025.